Genovese G, et al.. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329:841–845.

• PubMed
Genovese G, . Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329:841–845.)| false
• Search Google Scholar
• Export Citation

Stanescu HC, et al.. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med 2011; 364:616–626.

• PubMed
Stanescu HC, . Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med 2011; 364:616–626.)| false
• Search Google Scholar
• Export Citation

Kiryluk K, et al.. Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat Genet 2014; 46:1187–1196.

• PubMed
Kiryluk K, . Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat Genet 2014; 46:1187–1196.)| false
• Search Google Scholar
• Export Citation

Beck LH Jr., et al.. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361:11–21.

• PubMed
Beck LH Jr., . M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361:11–21.)| false
• Search Google Scholar
• Export Citation

Tomas NM, et al.. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 2014; 371:2277–2287.

• PubMed
Tomas NM, . Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 2014; 371:2277–2287.)| false
• Search Google Scholar
• Export Citation

Klein J, et al.. The role of urinary peptidomics in kidney disease research. Kidney Int 2016; 89:539–545.

• PubMed
Klein J, . The role of urinary peptidomics in kidney disease research. Kidney Int 2016; 89:539–545.)| false
• Search Google Scholar
• Export Citation

Wada Y, et al.. Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/Proteome Initiative multi-institutional study of IgA1. Mol Cell Proteomics 2010; 9:719–727.

• PubMed
Wada Y, . Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/Proteome Initiative multi-institutional study of IgA1. Mol Cell Proteomics 2010; 9:719–727.)| false
• Search Google Scholar
• Export Citation

Takahashi K, et al.. Naturally occurring structural isomers in serum IgA1 O-glycosylation. J Proteome Res 2012; 11:692–702.

• PubMed
Takahashi K, . Naturally occurring structural isomers in serum IgA1 O-glycosylation. J Proteome Res 2012; 11:692–702.)| false
• Search Google Scholar
• Export Citation

Kiryluk K, Novak J. The genetics and immunobiology of IgA nephropathy. J Clin Invest 2014; 124:2325–2332.

• PubMed
Kiryluk K, Novak J. The genetics and immunobiology of IgA nephropathy. J Clin Invest 2014; 124:2325–2332.)| false
• Search Google Scholar
• Export Citation

Kiryluk K, et al.. GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway. PLoS Genet 2017; 13(2):e1006609.

• PubMed
Kiryluk K, . GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway. PLoS Genet 2017; 13(2):e1006609.)| false
• Search Google Scholar
• Export Citation

Barrios C, et al.. Glycosylation profile of IgG in moderate kidney dysfunction. J Am Soc Nephrol 2016; 27:933–941.

• PubMed
Barrios C, . Glycosylation profile of IgG in moderate kidney dysfunction. J Am Soc Nephrol 2016; 27:933–941.)| false
• Search Google Scholar
• Export Citation